IELTS Academic Reading Practice Test 346

In the Europe of the late seventeenth century, physicians thought carefully about the air a patient breathed, the food they ate and the balance of the humours in their bodies, but hardly ever about the work they did. Bernardino Ramazzini changed that. Born in 1633 in Carpi, a small town near Modena in northern Italy, he studied medicine at Parma and then returned to practise in the region where he had grown up. He later held a chair at the university of Modena, and in 1700, at the age of sixty-six, he was appointed to the chair of practical medicine at Padua, then one of the most respected medical schools in Europe.

Ramazzini's interest in occupation grew out of his medical practice. Visiting patients in their homes and workshops, he noticed that men and women who followed particular trades tended to suffer from particular complaints, and that many of these complaints were missing from the textbooks. In 1700 he set out his observations in a book whose Latin title, De Morbis Artificum Diatriba, is usually translated as Diseases of Workers. It was not a systematic survey but a collection of descriptions, each organised around a trade, and it grew with the years: an expanded edition appeared in 1713, the year before he died.

His method was unusually direct. Rather than relying on the authority of ancient writers, Ramazzini went to workshops, watched craftsmen at work, examined the materials they handled and asked them about their symptoms. He also changed the questions that a doctor was expected to ask. Medical teaching inherited from Hippocrates listed a series of enquiries about a patient's way of life; Ramazzini proposed that one more be added: what trade does he follow? The question, he argued, should be put to everyone, since the answer often pointed to the cause of the illness.

Miners and stonemasons came first in his account, and the picture he drew is recognisable today. Men who cut rock underground and inhaled fine dust developed coughs, breathlessness and a slow wasting of the body, and many died young. Ramazzini connected these symptoms with the dust of the mine rather than with damp or with bad air in general, and he observed that the problem was worse in deep workings, where the dust hung in the air and ventilation was poor. Goldsmiths, who ground metals and breathed in metallic particles, suffered in a similar way.

Other trades produced other patterns of illness. Potters who glazed their wares with lead compounds developed trembling of the hands, weakness in the limbs and a slow decline in health, and painters who used lead-based white pigment were affected too. Gilders and mirror-makers, who worked with mercury, were liable to tremors, difficulty in speaking and disturbed behaviour, and Ramazzini recorded how quickly the symptoms could appear in a young apprentice. He was not the first physician to notice such cases, but his book was the first to bring them together under the heading of occupation.

He also noticed complaints that his contemporaries would not have regarded as diseases of work at all. Women who sifted and measured grain through sieves breathed in flour dust all day and suffered from coughs and a sense of suffocation, and bakers and millers were affected in the same way. People who cleaned out sewers and privies worked in foul air and came home with fevers and sickness. Even scholars, bent over their desks for long hours, suffered from the consequences of a sedentary life.

Having identified a hazard, Ramazzini did not simply describe it. He argued that much of the damage could be reduced by changes to the way work was organised: by opening windows and moving work outdoors where possible, by shifting a worker away from the source of dust or fumes, by covering the mouth and nose with a cloth, and by allowing regular rest breaks. He advised miners to ventilate their galleries and to avoid the deepest shafts in the hottest months. Some of these suggestions were impractical in the conditions of the time, and he knew it, but the principle that a disease might be prevented by altering the workplace was new.

The book was well received by learned readers across Europe and was reprinted and translated into several languages during the following century. Yet its practical influence was limited. Medicine in the eighteenth century was more interested in the workings of the individual body than in the circumstances of a trade, and the doctors who attended sick workers had little power to change a workshop. It was only in the nineteenth century, with the growth of factories and the campaigns that produced the first factory legislation, that the systematic study of occupational disease became established.

Ramazzini is now often described as the father of occupational medicine, and the description is deserved rather than merely conventional. He did not identify the substances that harmed workers, and many of his explanations of how they did so were mistaken. What he established was a habit of mind: that the question of what a person does all day belongs in the consulting room, and that the answer is part of the medical evidence.

Every thought, movement and sensation depends on cells that are specialised for sending messages quickly. The human brain is thought to contain something like eighty-six billion of them, and each is connected to hundreds or thousands of others. A signal has to travel from the base of the spine to a muscle in the foot, a distance of up to a metre, in a small fraction of a second, and must then be passed on to the next cell in the chain without losing its strength. Nerve cells, or neurons, achieve this with a combination of electrical and chemical events.

A neuron has a shape that follows its function. Branching fibres called dendrites spread out at one end and receive signals from other cells. These connect to the cell body, which contains the nucleus and the machinery that keeps the cell alive. From the cell body a single long fibre, the axon, carries the message away; in the neurons that run from the spinal cord to the toes, the axon may stretch for a metre. Near its end the axon divides into branches, each finishing in a swollen tip where the electrical message is converted into a chemical one.

Even when a neuron is silent, work is going on at its surface. The membrane that surrounds the cell is studded with protein channels and pumps that move charged atoms, or ions, in and out. Sodium ions are kept largely outside the cell and potassium ions largely inside, and because the traffic is unequal the inside of the membrane carries a small negative charge relative to the outside, typically about seventy millivolts. This resting potential is a store of energy, held in place by pumps that spend part of the cell's own fuel to maintain it. A neuron is, in effect, a charged battery waiting to be discharged.

The discharge begins when a stimulus pushes the voltage at one point on the membrane past a threshold. Channels that admit sodium open, positive charge floods in and the inside briefly becomes positive; this spike is the action potential. Almost at once other channels open to let potassium out, restoring the negative charge, and for a moment afterwards the membrane cannot fire again. Because the spike is generated afresh at each point along the fibre, it does not fade as it travels. Its size does not depend on the strength of the stimulus either: a neuron either fires completely or not at all, and a stronger stimulus produces more frequent impulses rather than larger ones.

Speed matters, and the nervous system has two ways of increasing it. The first is to make the axon wider, since a thicker fibre conducts faster. The second, used by most of the fibres that connect distant parts of the body, is insulation. Glial cells wrap the axon in layers of a fatty substance called myelin, leaving small gaps, known as nodes of Ranvier, at intervals of about a millimetre. The impulse leaps from one gap to the next rather than crawling along every patch of membrane. A myelinated fibre can carry a signal at up to about 120 metres per second, while a thin unmyelinated one manages less than two.

At the end of the axon the electrical message stops and chemistry takes over. The tip contains small sacs filled with molecules called neurotransmitters, and when an impulse arrives these sacs fuse with the membrane and release their contents into the narrow gap, about twenty nanometres wide, that separates one neuron from the next. On the far side, receptors on the receiving membrane recognise the molecules and open channels in response. Many different transmitters are known; some, such as glutamate, usually excite the receiving cell, while others, such as GABA, usually inhibit it. The signal is ended when the molecules are broken down or taken back into the tip that released them.

A single neuron may receive thousands of synapses, and whether it fires depends on the sum of what arrives. Signals that come close together in time and at neighbouring points add up; if the total at the place where the axon leaves the cell body crosses the threshold, an impulse is generated. This arrangement allows neurons to combine information and to be selective, responding to a particular pattern of input rather than to any input at all. It also underlies learning: synapses that are used repeatedly become stronger, a principle often summarised as cells that fire together wiring together.

Much, however, remains uncertain. The basic mechanism of the impulse has been understood since the middle of the twentieth century, but how patterns of impulses represent a memory, a face or a word is still unknown. Dendrites were long assumed to be passive collectors of signals; it is now clear that they perform computations of their own, and how much of the brain's processing happens there is disputed. The claim that new neurons are produced in the adult human brain has also been contested, with studies pointing in different directions.

Research methods have changed rapidly. Fine glass electrodes can record the activity of a single neuron, while patches of membrane can be isolated to study individual channels. Optogenetics allows researchers to switch particular populations of neurons on or off with light, and imaging techniques let them watch thousands of cells at once in a living animal. The wiring of the small worm Caenorhabditis elegans, which has exactly 302 neurons, has been mapped completely; the human brain, with its billions, remains far beyond any such map.

Anyone who has woken at three in the morning with a pain in the chest, or been told that a relative has received a frightening diagnosis, knows what happens next: a phone or a laptop is opened and the search begins. People look up symptoms, treatments, side effects and survival rates, for themselves and for those they care about. Some of what they find is produced by national health services and medical charities and has been carefully reviewed; some is written by enthusiasts, sold by clinics or generated by software. The question for governments is whether all of it should be checked by an expert before it appears.

The argument for expert checking is easy to state. Medicine is technical, the consequences of error can be severe, and few readers have the training to notice when a confident paragraph is misleading. Someone who follows bad advice about a dose, stops taking a treatment that is keeping a condition under control, or pays for a therapy that has never been tested may be harmed in ways that no later correction can repair. Falsehood travels quickly, and the term infodemic, which came into wide use during the covid-19 pandemic, captures the sense that it now spreads as efficiently as disease itself. On this view, a page about health should carry the same sort of assurance as a prescribed medicine.

The difficulty is that the remedy would have to be applied to an enormous and constantly changing body of material. Health information is written by universities, hospitals, journalists, patients, companies and hobbyists, and much of it is revised daily. Reviewing all of it would require an army of clinicians. There is also a harder objection. Expert agreement is not the same as truth. For decades the medical consensus held that stomach ulcers were caused by stress and excess acid, and the researchers who argued that a bacterium was responsible were treated with scepticism before they were proved right. A system that admitted only the accepted view would have silenced them.

Against the professional model stands the open one. The largest volunteer-written encyclopaedia is consulted by the public and by clinicians alike, and its medical articles are watched over by editors who remove obvious errors and add references; patient communities, meanwhile, hold knowledge about rare conditions that no single clinic possesses. Such sites can be corrected within minutes of a mistake being noticed. Their weakness is equally plain: the quality of an article depends on who happens to be paying attention, and a page can look authoritative while being years out of date.

The mistake, it seems to me, is to treat all health information as a single category. A description of what a migraine feels like is not the same kind of claim as a recommendation to give a child a particular dose of a medicine, and advice on managing a long-term condition at home carries different risks from a promise to cure cancer. What matters is the consequence of being wrong. A sensible system would concentrate expert attention where a mistake would do serious damage and leave the rest to other safeguards.

Those safeguards begin with transparency. A reader should be able to see, without hunting, who wrote a page, when it was last revised, what evidence it rests on and whether anyone with a commercial interest has approved it. A page produced by a hospital pharmacy and a page produced by a company selling a supplement should not look alike, and at present they often do. Labels of this kind do not make a claim true, but they give the reader the one thing that is usually missing: a reason to trust or to doubt.

Responsibility also lies with the companies that decide what is seen. Search engines and social platforms do not merely store material; their ranking systems determine which page is read first, and those systems reward whatever attracts attention. A frightening claim, shared widely, will rise above a careful and dull one. Some governments have begun to require the largest platforms to assess the risks their services create, including risks to health. That seems to me a more realistic lever than the review of individual pages.

Education has a part to play as well. Teaching people to ask who is behind a claim, to look for a date and to notice when a page is selling something is worthwhile, and schools have begun to do it. But it is unfair to place the whole burden on individuals. The same reader may appraise a web page calmly on a good day and grasp at the first answer in a panic at three in the morning. Skill is not a substitute for a decent environment.

What, then, should be done? A rule requiring every health page to be approved before publication would be unworkable, and it would slow the spread of good information as well as bad. The better approach is a graded one: expert review for the small number of high-stakes claims that can cause direct harm; a widely recognised mark for material that has been checked and kept up to date, funded publicly so that it does not belong only to those who can pay; and platform rules that make the promotion of dangerous claims costly. None of this is as tidy as a single gate, but it fits what is known about error, speed and human attention.

The aim, after all, is not to decide who may speak about medicine. It is to ensure that someone who searches in fear finds something trustworthy, and knows why it deserves to be trusted.